Mark C. Richter

735 total citations
5 papers, 266 citations indexed

About

Mark C. Richter is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mark C. Richter has authored 5 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Mark C. Richter's work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Microtubule and mitosis dynamics (2 papers). Mark C. Richter is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Microtubule and mitosis dynamics (2 papers). Mark C. Richter collaborates with scholars based in United States and United Kingdom. Mark C. Richter's co-authors include Aidan G. Gilmartin, Jeffrey R. Jackson, Maureen R. Bleam, Sylvie Laquerre, Gary K. Smith, Gopinath Ganji, Rakesh Kumar, Tajhal Dayaram, Melody Diamond and David Sutton and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Therapy.

In The Last Decade

Mark C. Richter

5 papers receiving 265 citations

Peers

Countries citing papers authored by Mark C. Richter

Since Specialization

Citations

This map shows the geographic impact of Mark C. Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Richter more than expected).

Fields of papers citing papers by Mark C. Richter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Richter. The network helps show where Mark C. Richter may publish in the future.

Co-authorship network of co-authors of Mark C. Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Richter. A scholar is included among the top collaborators of Mark C. Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Richter. Mark C. Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Centyrin ligands for extrahepatic delivery of siRNA 2021 ·Molecular Therapy ·(unknown), Shalom D. Goldberg, Christopher S. Theile, (unknown), Kathleen Haskell, (unknown), (unknown), Rubina Parmar, Muthiah Manoharan, Mark C. Richter, Mei‐Zhen Wu, (unknown), Vasant Jadhav, Martin A. Maier, Laura Sepp‐Lorenzino, Karyn T. O’Neil, Vadim Dudkin	33
2	Abstract A11: Preclinical assessment of CD3 bispecific antibody efficacy: A comparison of humanized mouse models bearing xenografts and syngeneic mouse models using surrogate antibodies 2018 ·Cancer Research ·(unknown), Krista Menard, (unknown), (unknown), Emily Chen, (unknown), Kristen Chevalier, Karla R. Wiehagen, Mark C. Richter, Gerald Chu, (unknown), Anna C. Hughes, John Alvarez, Raluca Verona, Colleen Kane, Sheri L. Moores, Sylvie Laquerre, Joseph A. Erhardt, Kathryn Packman	1
3	WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma 2015 ·PLoS ONE ·Mark C. Richter, Tajhal Dayaram, Aidan G. Gilmartin, Gopinath Ganji, (unknown), (unknown), Jason M. Shohet, Lawrence A. Donehower, Rakesh Kumar	59
4	Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability 2010 ·Molecular Cancer Therapeutics ·Yan Degenhardt, Joel Greshock, Sylvie Laquerre, Aidan G. Gilmartin, Junping Jing, Mark C. Richter, Xiping Zhang, Maureen R. Bleam, Wendy S. Halsey, Ashley M. Hughes, Christopher Moy, (unknown), Scott Powers, Kurtis E. Bachman, Jeffrey R. Jackson, Barbara Weber, Richard Wooster	73
5	Distinct Concentration-Dependent Effects of the Polo-like Kinase 1–Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis 2009 ·Cancer Research ·Aidan G. Gilmartin, Maureen R. Bleam, Mark C. Richter, Symon G. Erskine, Ryan G. Kruger, (unknown), Daniel F. Hassler, Gary K. Smith, Richard R. Gontarek, (unknown), David Sutton, Melody Diamond, Jeffrey R. Jackson, Sylvie Laquerre	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact